What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Surgery
Her main research concerns Surgery, Pancreatic disease, Pancreaticoduodenectomy, Radiation therapy and Colorectal cancer.
Her work deals with themes such as Cancer and Perineural invasion, which intersect with Surgery.
Her Pancreatic disease study is associated with Pancreas.
The various areas that Karen R. Cleary examines in her Pancreaticoduodenectomy study include Pancreatectomy and Radiology.
Her Radiation therapy research includes elements of Perioperative, Chemotherapy and Adenocarcinoma.
Her biological study spans a wide range of topics, including Rectum, Metastasis and Lymph node, Pathology.
Her most cited work include:
- Mutations in the p53 gene occur in diverse human tumour types (2385 citations)
- Expression of Vascular Endothelial Growth Factor and Its Receptor, KDR, Correlates with Vascularity, Metastasis, and Proliferation of Human Colon Cancer (1180 citations)
- The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells (580 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Pathology, Colorectal cancer, Surgery, Internal medicine and Adenocarcinoma.
Her Carcinoma, Immunohistochemistry and Mucin study, which is part of a larger body of work in Pathology, is frequently linked to Basic fibroblast growth factor, bridging the gap between disciplines.
Her Colorectal cancer study combines topics from a wide range of disciplines, such as Rectum, Antigen, Lymph node and Primary tumor, Metastasis.
She has included themes like Cancer research and Angiogenesis in her Metastasis study.
Her Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Oncology.
In her research, Pancreatic cancer and Neoplasm is intimately related to Pancreas, which falls under the overarching field of Adenocarcinoma.
She most often published in these fields:
- Pathology (34.91%)
- Colorectal cancer (27.81%)
- Surgery (26.04%)
What were the highlights of her more recent work (between 1999-2008)?
- Surgery (26.04%)
- Colorectal cancer (27.81%)
- Internal medicine (26.63%)
In recent papers she was focusing on the following fields of study:
Karen R. Cleary mainly investigates Surgery, Colorectal cancer, Internal medicine, Pancreas and Pancreatic disease.
Her research integrates issues of Tegafur, Rectum, Fluorouracil, Nuclear medicine and Lymph node in her study of Colorectal cancer.
Her Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Immunology and Oncology.
Karen R. Cleary has researched Pancreas in several fields, including Surgical oncology, Malignancy, Pancreatic cancer and Adenocarcinoma.
Her Adenocarcinoma study combines topics in areas such as 2-Amino-1-methyl-6-phenylimidazopyridine and Proliferating cell nuclear antigen.
The various areas that Karen R. Cleary examines in her Radiation therapy study include Pancreatectomy and Chemotherapy.
Between 1999 and 2008, her most popular works were:
- Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head (574 citations)
- Simplified Staging for Hepatocellular Carcinoma (554 citations)
- Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. (297 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Karen R. Cleary focuses on Surgery, Pancreatic disease, Pancreaticoduodenectomy, Radiation therapy and Internal medicine.
Her Survival rate study in the realm of Surgery interacts with subjects such as Univariate analysis.
Her Pancreatic disease research is classified as research in Pancreas.
Her Pancreas course of study focuses on Aurora Kinase A and Pancreatic cancer and Metastasis.
Her research in Radiation therapy intersects with topics in Survival analysis and Chemotherapy.
Her Chemotherapy research integrates issues from Urology and Adenocarcinoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
